ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CTXR Citius Pharmaceuticals Inc

0.707
0.00 (0.00%)
Pre Mercado
Última actualización: 03:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Citius Pharmaceuticals Inc CTXR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.707 03:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.707
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:05PRNUSCitius Pharmaceuticals Announces Closing of $15 Million..
26/4/202407:00PRNUSCitius Pharmaceuticals Announces $15 Million Registered..
11/4/202407:30PRNUSCitius Pharmaceuticals Announces Addition of City of Hope to..
04/4/202407:30PRNUSCitius Pharmaceuticals to Present at the LD Micro..
18/3/202407:30PRNUSCitius Pharmaceuticals Announces FDA Acceptance of the BLA..
07/3/202407:30PRNUSCitius Pharmaceuticals, Inc. Secures $2.4 million through..
03/3/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202406:30PRNUSCitius Pharmaceuticals Announces Filing of Form S-3 Shelf..
23/2/202415:23EDGAR2Form S-3 - Registration statement under Securities Act of..
23/2/202415:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/2/202407:30PRNUSCitius Pharmaceuticals to Participate in Upcoming BIO CEO..
15/2/202407:45EDGAR2Form 8-K - Current report
14/2/202415:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202415:30PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal First Quarter..
14/2/202408:18EDGAR2Form 8-K - Current report
14/2/202407:01PRNUSCitius Pharmaceuticals Resubmits the Biologics License..
26/1/202415:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202415:05EDGAR2Form DEF 14A - Other definitive proxy statements
23/1/202415:05EDGAR2Form 8-K - Current report
23/1/202407:30PRNUSCitius Pharmaceuticals Announces Nomination of..
05/1/202415:05EDGAR2Form 8-K - Current report
02/1/202415:04EDGAR2Form 8-K - Current report
02/1/202407:31PRNUSCitius Pharmaceuticals Completes Enrollment in Pivotal Phase..
02/1/202407:30PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023..
29/12/202315:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/11/202307:30PRNUSCitius Pharmaceuticals to Participate in the Sidoti..
31/10/202307:45PRNUSCitius Pharmaceuticals Announces Publication in Frontiers of..
24/10/202306:58EDGAR2Form 425 - Prospectuses and communications, business..
24/10/202306:53EDGAR2Form 8-K - Current report
24/10/202306:30PRNUSCitius Pharmaceuticals Executes Definitive Agreement to..
12/10/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202315:30EDGAR2Form 8-K - Current report
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
18/9/202315:30PRNUSCitius Pharmaceuticals Reschedules Participation in Sidoti..
15/9/202315:30EDGAR2Form 8-K - Current report
13/9/202315:30PRNUSCitius Pharmaceuticals Mourns the Loss of Board Member,..
11/9/202308:53EDGAR2Form 8-K - Current report
08/9/202307:40EDGAR2Form 8-K - Current report
08/9/202307:00PRNUSCitius Pharmaceuticals, Inc. Receives Regulatory Guidance..
06/9/202315:30PRNUSCitius Pharmaceuticals to Participate in H.C. Wainwright and..
15/8/202308:25EDGAR2Form 8-K - Current report
14/8/202315:15PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Third Quarter..
14/8/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:15EDGAR2Form 8-K - Current report
10/8/202307:37PRNUSCitius Pharmaceuticals Reaches 92 Event Milestone in..
31/7/202315:15EDGAR2Form 8-K - Current report
29/7/202315:16PRNUSCitius Pharmaceuticals, Inc. Receives a Complete Response..

Su Consulta Reciente

Delayed Upgrade Clock